Jane Larkindale

Jane Larkindale is currently the Vice President of Clinical Science at PepGen, with previous experience as the Executive Director of Rare Disease Cures Accelerator at Critical Path Institute. Jane has also worked as the Vice President of Research at the Muscular Dystrophy Association and as a Research Scientist at the University of Arizona. Jane holds a DPhil in Plant Sciences from the University of Oxford and a BSc in Plant Biotechnology and Physics from the University of Otago.